CCRAS hosts national consultative meet on traditional medicine
Signs MoUs with Shri Krishna Ayush University and Dabur India
Signs MoUs with Shri Krishna Ayush University and Dabur India
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
This tie-up will have no impact on any other brands of the company
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
The facility was inspected from May 7 to May 17, 2024
Renews GMP certifications for India and Malaysia sites
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
The company will now explore a buyer for its manufacturing site and exit in due course
Subscribe To Our Newsletter & Stay Updated